Global Sales of Antibodies to cross a valuation of US$ 3,000 Mn by 2022-end | Thermo Fisher Scientific, Inc., Sigma Aldrich Corp
Demand for antibodies is anticipated to remain steady across the globe in the foreseeable future. Rising occurrence of chronic diseases such as diabetes, cancer, and [read full press release…]